PYSZCZYMUKA GREG bought AYTU
December 31, 2023 · Form 4 insider transaction
PYSZCZYMUKA GREG bought 209 shares of Aytu BioPharma, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
209
Price
N/A
Total value
N/A
InsiderPYSZCZYMUKA GREG
RoleOfficer, Director
CompanyAytu BioPharma, Inc. (AYTU)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 31, 2023
Filing dateJanuary 2, 2024
Shares owned after22,560
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest as follows: One-third on March 31, 2023; 1/12th of the original grant quarterly thereafter through March 31, 2025. Settlement of vested RSUs will occur as soon as practicable following vesting.